Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KEMPER CorpKMPR · Entity 719 | Director | August 10, 2026 | August 11, 2026 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director · CHIEF EXECUTIVE OFFICER | March 19, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KEMPER Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,802 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Purchase · Acquired 5,000 · Balance 31,802 |
Teladoc Health, Inc.
Report date March 19, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 197,728 |
Reported balance
After 2024-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-19 · Grant · Acquired 197,728 · Balance 197,728 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2021 Filed Mar 5, 2021 22:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002975 · edgar.xml · derivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. F3 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002975 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 12,685 | $206.99 | $2,625,668.15 |
DisclosureSEC source: 0001179110-21-002975 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,634 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 22,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · derivative · entry 12 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,944 Underlying: Common Stock · 22,944 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F13 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. F13 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 15,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · derivative · entry 11 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,954 Underlying: Common Stock · 15,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F10 · derivative.expiration_date: On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 46,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · derivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,430 Underlying: Common Stock · 46,430 shares Expires not disclosed F11 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F14 · shares: Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. F9 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. F9 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,207 Underlying: Common Stock · 9,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $223.53 | $6,706,011.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,319 F4 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F5 · price: Represents the weighted average price of transactions ranging from $216.40 to $231.14. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 15,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 12,674 | $224.28 | $2,842,550.07 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,739 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 13,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · derivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2019 and March 1 each subsequent year. F7 · derivative.expiration_date: On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2019 and March 1 each subsequent year. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 13,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · derivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,281 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002796 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $271.06 | $8,131,800.00 |
DisclosureSEC source: 0001179110-21-001316 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,188 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $266.66 to $280.44. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $200.15 | $6,004,500.00 |
DisclosureSEC source: 0001179110-21-000318 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,188 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $198.26 to $202.50. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2020 Filed Feb 10, 2021 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001504 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,188 Read SEC document |
| December 14, 2020 Filed Feb 10, 2021 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001504 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,188 Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,000 | $200.52 | $1,002,600.00 |
DisclosureSEC source: 0001179110-20-011715 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,318 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $200.12 to $201.18. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $194.27 | $4,856,750.00 |
DisclosureSEC source: 0001179110-20-011598 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,318 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $192.10 to $198.66. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2020 Filed Feb 10, 2021 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001504 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,188 Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,000 | $200.27 | $1,001,350.00 |
DisclosureSEC source: 0001179110-20-010859 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,593 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F3 · price: Represents the weighted average price of transactions ranging from $200.22 to $200.67. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 03, 2020 Filed Nov 6, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 310 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-010859 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 310 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| November 03, 2020 Filed Nov 6, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $193.76 | $4,844,000.00 |
DisclosureSEC source: 0001179110-20-010859 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642,593 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $190.48 to $196.86. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 03, 2020 Filed Nov 6, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 310 | $6.01 | $1,863.10 |
DisclosureSEC source: 0001179110-20-010859 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2020 Filed Oct 9, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-010367 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310 Underlying: Common Stock · 30,000 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| October 06, 2020 Filed Oct 9, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $222.26 | $6,667,800.00 |
DisclosureSEC source: 0001179110-20-010367 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,283 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $217.44 to $225.50. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 06, 2020 Filed Oct 9, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $6.01 | $180,300.00 |
DisclosureSEC source: 0001179110-20-010367 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-009579 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,310 Underlying: Common Stock · 30,000 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $221.89 | $6,656,700.00 |
DisclosureSEC source: 0001179110-20-009579 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,283 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $217.20 to $224.63. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $6.01 | $180,300.00 |
DisclosureSEC source: 0001179110-20-009579 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-008792 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,310 Underlying: Common Stock · 30,000 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $245.96 | $7,378,800.00 |
DisclosureSEC source: 0001179110-20-008792 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,283 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $236.72 to $252.57. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $6.01 | $180,300.00 |
DisclosureSEC source: 0001179110-20-008792 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 21:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-008170 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,310 Underlying: Common Stock · 30,000 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 21:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $218.71 | $6,561,300.00 |
DisclosureSEC source: 0001179110-20-008170 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,283 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $214.64 to $223.57. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 21:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $6.01 | $180,300.00 |
DisclosureSEC source: 0001179110-20-008170 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2020 Filed Feb 10, 2021 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001504 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,188 Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,933 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-20-007003 · edgar.xml · derivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,310 Underlying: Common Stock · 1,933 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,067 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-20-007003 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,067 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $168.42 | $4,210,500.00 |
DisclosureSEC source: 0001179110-20-007003 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,283 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F2 · price: Represents the weighted average price of transactions ranging from $165.23 to $172.58. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,933 | $6.01 | $11,617.33 |
DisclosureSEC source: 0001179110-20-007003 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 23,067 | $1.67 | $38,521.89 |
DisclosureSEC source: 0001179110-20-007003 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,933 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · derivative · entry 12 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,310 Underlying: Common Stock · 1,933 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F10 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested in 36 substantially equal monthly installments thereafter. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,067 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · derivative · entry 11 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,067 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F9 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 substantially equal monthly installments thereafter. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 300 | $172.58 | $51,774.00 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,283 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 100 | $171.32 | $17,132.00 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,583 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 600 | $170.41 | $102,247.98 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,683 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F8 · price: Represents the weighted average price of transactions ranging from $170.31 to $170.51, inclusive. Read SEC document |
| June 02, 2020 Filed May 10, 2021 20:29 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,794 | $169.66 | $1,322,309.78 |
DisclosureSEC source: 0001179110-21-005054 · edgar.xml · nonDerivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 672,283 F1 · deemedExecutionDate: The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. F7 · price: Represents the weighted average price of transactions ranging from $169.28 to $170.27, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.